Cytek Biosciences Statistics
NASDAQ: CTKBIndustrialsBiotechnology: Laboratory Analytical InstrumentsUSD
6.12-0.20 (-3.16%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Cytek Biosciences by the numbers
Cytek Biosciences has a market capitalization of $800.4 million based on 130.78M shares outstanding. With trailing EPS of $-0.63, Cytek Biosciences is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 8.7% above its 50-day average and 30.2% above its 200-day average.
Average daily trading volume is 1.31M shares, or about $8.0 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
CTKB valuation vs. peer median
| Metric | CTKB | Peer median | Difference |
|---|---|---|---|
| Market cap | $800.40M | $84.48M | +847% |
| Avg. volume | 1.31M | 649.32K | +102% |
Peer median across 8 companies: PACB, NAUT, LAB, QTRX, SEER, HBIO, RPID, PRPO.
Valuation
- Market cap
- $800.40M
- Forward P/E
- 87.43
- Price / sales (latest FY)
- 3.97
- EPS (TTM)
- $-0.63
- Shares outstanding
- 130.78M
Price and trading
- Previous close
- 6.32
- Open
- 6.28
- Day range
- 5.99 – 6.39
- 52-week range
- 3.31 – 6.39
- 52-week change
- +4.08%
- Beta
- —
- Volume
- 1.77M
- Average volume
- 1.31M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 4, 2026
Additional statistics
- Market Cap
- 800.40M
- Forward Pe
- 87.43
- Eps
- -0.63
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 6.39
- Week52 Low
- 3.31
- Avg Volume
- 1.31M
- Shares Outstanding
- 130.78M
- Ma50
- 5.63
- Ma200
- 4.70
- Earnings Date
- Nov 4, 2026
- Pct From52w High
- -4.15%
- Pct From52w Low
- 84.89%